U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT06929910) titled 'Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing.' on April 08.
Brief Summary: The goal of this observational study is to investigate the real-world treatment landscape of patients with metastatic cancer and determine the role of ctDNA in monitoring treatment response in patients with metastatic cancer who have undergone K4Care testing.
Study Start Date: April 09
Study Type: OBSERVATIONAL
Condition:
Metastatic Cancers
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Gene Solutions
Published by HT Digital Content Services with permission from Health Daily Digest....